Detalhe da pesquisa
1.
Gut Microbiome in Progressive Multiple Sclerosis.
Ann Neurol
; 89(6): 1195-1211, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33876477
2.
Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational study.
Mult Scler
; 28(7): 1146-1150, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35475382
3.
7 T imaging reveals a gradient in spinal cord lesion distribution in multiple sclerosis.
Brain
; 143(10): 2973-2987, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32935834
4.
7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions.
Mult Scler
; 26(2): 177-187, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31714181
5.
Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.
Brain
; 142(3): 633-646, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30715195
6.
Automatic segmentation of the spinal cord and intramedullary multiple sclerosis lesions with convolutional neural networks.
Neuroimage
; 184: 901-915, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30300751
7.
Gradient nonlinearity effects on upper cervical spinal cord area measurement from 3D T1 -weighted brain MRI acquisitions.
Magn Reson Med
; 79(3): 1595-1601, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28617996
8.
Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability.
BMC Neurol
; 17(1): 172, 2017 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28874119
9.
A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis.
Int J Neurosci
; 127(5): 396-403, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27143245
10.
Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.
Int J Neurosci
; 127(11): 971-980, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28100092
11.
The effect of intramuscular interferon beta-1a on spinal cord volume in relapsing-remitting multiple sclerosis.
BMC Med Imaging
; 16(1): 56, 2016 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27716096
12.
T1- vs. T2-based MRI measures of spinal cord volume in healthy subjects and patients with multiple sclerosis.
BMC Neurol
; 15: 124, 2015 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-26227960
13.
Exploring the effect of glatiramer acetate on cerebral gray matter atrophy in multiple sclerosis.
J Neurol Sci
; 444: 120501, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36481574
14.
Multiple sclerosis lesions that impair memory map to a connected memory circuit.
J Neurol
; 270(11): 5211-5222, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37532802
15.
Intersite brain MRI volumetric biases persist even in a harmonized multisubject study of multiple sclerosis.
J Neuroimaging
; 33(6): 941-952, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37587544
16.
COVID-19 mRNA vaccination leading to CNS inflammation: a case series.
J Neurol
; 269(3): 1093-1106, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480607
17.
Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS.
Mult Scler J Exp Transl Clin
; 8(1): 20552173211069348, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35035990
18.
Exacerbation of Multiple Sclerosis by BRAF/MEK Treatment for Malignant Melanoma: The Central Vein Sign to Distinguish Demyelinating Lesions From Metastases.
J Investig Med High Impact Case Rep
; 9: 23247096211033047, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34308699
19.
Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis.
Mult Scler
; 16(1): 39-44, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19965516
20.
Regional microglial activation in the substantia nigra is linked with fatigue in MS.
Neurol Neuroimmunol Neuroinflamm
; 7(5)2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32769103